Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review

被引:32
作者
Vitale, Elsa [1 ]
Rizzo, Alessandro [2 ]
Santa, Kazuki [3 ]
Jirillo, Emilio [4 ]
机构
[1] IRCCS, Sci Directorate, Ist Tumori Giovanni Paolo II, Viale Orazio Flacco 65, I-70124 Bari, Italy
[2] IRCCS, Med Oncol, Ist Tumori Giovanni Paolo II, Viale Orazio Flacco 65, I-70124 Bari, Italy
[3] Juntendo Univ, Fac Med Sci, 6-8-1 Hinode, Urayasu, Chiba 2790013, Japan
[4] Univ Bari, Scuola Med, I-70121 Bari, Italy
来源
BIOLOGY-BASEL | 2024年 / 13卷 / 05期
关键词
cancer risk; inflammation; metabolic syndrome; oncogenesis; oxidative stress; FATTY LIVER-DISEASE; PROSTATE-CANCER; INSULIN-RESISTANCE; DIABETES-MELLITUS; COLORECTAL-CANCER; OXIDATIVE STRESS; OBESITY; BREAST; EPIDEMIOLOGY; MECHANISMS;
D O I
10.3390/biology13050352
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Individuals with metabolic syndrome exhibit simultaneously pro-thrombotic and a pro-inflammatory conditions which more probably can lead to cardiovascular disease progression, type 2 diabetes mellitus, and some types of cancer. The present scoping review is aimed at highlighting any relations between cancer risk, inflammation, and metabolic syndrome. A total of 20 manuscripts were identified and, among them, we identified some associations with breast cancer, colorectal cancer, esophageal adenocarcinoma, hepatocellular carcinoma (HCC), and cancer in general. Therefore, it could be deducted that cancer and its related progression may also depend on a latent chronic inflammatory condition associated with other concomitant conditions, including type 2 diabetes mellitus, metabolic syndrome, and obesity. Therefore, prevention may potentially help individuals to protect themselves from cancer.Abstract Background: Individuals with metabolic syndrome exhibit simultaneously pro-thrombotic and pro-inflammatory conditions which more probably can lead to cardiovascular diseases progression, type 2 diabetes mellitus, and some types of cancer. The present scoping review is aimed at highlighting the association between cancer risk, inflammation, and metabolic syndrome. Methods: A search strategy was performed, mixing keywords and MeSH terms, such as "Cancer Risk", "Inflammation", "Metabolic Syndrome", "Oncogenesis", and "Oxidative Stress", and matching them through Boolean operators. A total of 20 manuscripts were screened for the present study. Among the selected papers, we identified some associations with breast cancer, colorectal cancer, esophageal adenocarcinoma, hepatocellular carcinoma (HCC), and cancer in general. Conclusions: Cancer and its related progression may also depend also on a latent chronic inflammatory condition associated with other concomitant conditions, including type 2 diabetes mellitus, metabolic syndrome, and obesity. Therefore, prevention may potentially help individuals to protect themselves from cancer.
引用
收藏
页数:20
相关论文
共 99 条
[1]   Insulin-Like Growth Factor (IGF) System in Liver Diseases [J].
Adamek, Agnieszka ;
Kasprzak, Aldona .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
[2]   Colorectal cancer risk and dyslipidemia: A case-cohort study nested in an Italian multicentre cohort [J].
Agnoli, Claudia ;
Grioni, Sara ;
Sieri, Sabina ;
Sacerdote, Carlotta ;
Vineis, Paolo ;
Tumino, Rosario ;
Giurdanella, Maria Concetta ;
Pala, Valeria ;
Mattiello, Amalia ;
Chiodini, Paolo ;
Iacoviello, Licia ;
De Curtis, Amalia ;
Cattaneo, Leonardo ;
van Duijnhoven, Franzel J. B. ;
Panico, Salvatore ;
Krogh, Vittorio .
CANCER EPIDEMIOLOGY, 2014, 38 (02) :144-151
[3]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[4]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]   Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase [J].
Battelli, Maria Giulia ;
Bortolotti, Massimo ;
Polito, Letizia ;
Bolognesi, Andrea .
REDOX BIOLOGY, 2019, 21
[6]   Mediterranean Diet and Low-grade Subclinical Inflammation: The Moli-sani Study [J].
Bonaccio, Marialaura ;
Cerletti, Chiara ;
Iacoviello, Licia ;
de Gaetano, Giovanni .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (01) :18-24
[7]   A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers [J].
Bowers, Katherine ;
Albanes, Demetrius ;
Limburg, Paul ;
Pietinen, Pirjo ;
Taylor, Phil R. ;
Virtamo, Jarmo ;
Stolzenberg-Solomon, Rachael .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (07) :652-664
[8]   The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J].
Buzzetti, Elena ;
Pinzani, Massimo ;
Tsochatzis, Emmanuel A. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1038-1048
[9]   Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone [J].
Conteduca, Vincenza ;
Caffo, Orazio ;
Derosa, Lisa ;
Veccia, Antonello ;
Petracci, Elisabetta ;
Chiuri, Vincenzo Emanuele ;
Santoni, Matteo ;
Santini, Daniele ;
Fratino, Lucia ;
Maines, Francesca ;
Testoni, Sara ;
De Giorgi, Ugo .
PROSTATE, 2015, 75 (12) :1329-1338
[10]   The metabolic syndrome - A high-risk state for cancer? [J].
Cowey, Stephanie ;
Hardy, Robert W. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (05) :1505-1522